Recombinant vaccines are produced using recombinant DNA technology, with the help of a vector. These vaccines stimulate the immune system of an individual and provide immunity against various lethal disease.
These vaccines are safe and have less or no side-effects as compared to conventional vaccines, in the prevention of various diseases such as influenza, cholera, typhoid, and dengue.
Recombinant vaccines are also used in animals for prevention of diseases such as foot and mouth disease, pneumonia and septicemia, and pox disease. Vaccination results in the prevention of disease, by producing antibodies against the protein antigen of pathogenic microorganisms.
This report contains market size and forecasts of Recombinant Vaccines in global, including the following market information:
Global Recombinant Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Recombinant Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Recombinant Vaccines companies in 2021 (%)
The global Recombinant Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Subunit Recombinant Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Recombinant Vaccines include Merck & Co., Inc, Green Cross Corporation, Pfizer Inc., Bayer AG, Sanofi S A., Protein Science Corporation, GlaxoSmithKline Plc., Novartis AG and Bharat Biotech. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Recombinant Vaccines Market Segment Percentages, by Type, 2021 (%)
- Subunit Recombinant Vaccines
- Attenuated Recombinant Vaccines
- Vector Recombinant Vaccines
Global Recombinant Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Recombinant Vaccines Market Segment Percentages, by Application, 2021 (%)
- Recombinant Human Vaccines
- Animal Recombinant Vaccines
Global Recombinant Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Recombinant Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Recombinant Vaccines revenues share in global market, 2021 (%)
Key companies Recombinant Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Recombinant Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merck & Co., Inc
- Green Cross Corporation
- Pfizer Inc.
- Bayer AG
- Sanofi S A.
- Protein Science Corporation
- GlaxoSmithKline Plc.
- Novartis AG
- Bharat Biotech
Recombinant Vaccines Market, Global Outlook and Forecast 2022-2028
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Recombinant Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Vaccines Overall Market Size
2.1 Global Recombinant Vaccines Market Size: 2021 VS 2028
2.2 Global Recombinant Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Recombinant Vaccines Sales: 2017-2028
3 Company Landscape
3.1 Top Recombinant Vaccines Players in Global Market
3.2 Top Global Recombinant Vaccines Companies Ranked by Revenue
3.3 Global Recombinant Vaccines Revenue by Companies
3.4 Global Recombinant Vaccines Sales by Companies
3.5 Global Recombinant Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Recombinant Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Recombinant Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Vaccines Market Size Markets, 2021 & 2028
4.1.2 Subunit Recombinant Vaccines
4.1.3 Attenuated Recombinant Vaccines
4.1.4 Vector Recombinant Vaccines
4.2 By Type - Global Recombinant Vaccines Revenue & Forecasts
4.2.1 By Type - Global Recombinant Vaccines Revenue, 2017-2022
4.2.2 By Type - Global Recombinant Vaccines Revenue, 2023-2028
4.2.3 By Type - Global Recombinant Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Recombinant Vaccines Sales & Forecasts
4.3.1 By Type - Global Recombinant Vaccines Sales, 2017-2022
4.3.2 By Type - Global Recombinant Vaccines Sales, 2023-2028
4.3.3 By Type - Global Recombinant Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Recombinant Vaccines Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Recombinant Vaccines Market Size, 2021 & 2028
5.1.2 Recombinant Human Vaccines
5.1.3 Animal Recombinant Vaccines
5.2 By Application - Global Recombinant Vaccines Revenue & Forecasts
5.2.1 By Application - Global Recombinant Vaccines Revenue, 2017-2022
5.2.2 By Application - Global Recombinant Vaccines Revenue, 2023-2028
5.2.3 By Application - Global Recombinant Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Recombinant Vaccines Sales & Forecasts
5.3.1 By Application - Global Recombinant Vaccines Sales, 2017-2022
5.3.2 By Application - Global Recombinant Vaccines Sales, 2023-2028
5.3.3 By Application - Global Recombinant Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Recombinant Vaccines Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Recombinant Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Recombinant Vaccines Revenue & Forecasts
6.2.1 By Region - Global Recombinant Vaccines Revenue, 2017-2022
6.2.2 By Region - Global Recombinant Vaccines Revenue, 2023-2028
6.2.3 By Region - Global Recombinant Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Recombinant Vaccines Sales & Forecasts
6.3.1 By Region - Global Recombinant Vaccines Sales, 2017-2022
6.3.2 By Region - Global Recombinant Vaccines Sales, 2023-2028
6.3.3 By Region - Global Recombinant Vaccines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Recombinant Vaccines Revenue, 2017-2028
6.4.2 By Country - North America Recombinant Vaccines Sales, 2017-2028
6.4.3 US Recombinant Vaccines Market Size, 2017-2028
6.4.4 Canada Recombinant Vaccines Market Size, 2017-2028
6.4.5 Mexico Recombinant Vaccines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Recombinant Vaccines Revenue, 2017-2028
6.5.2 By Country - Europe Recombinant Vaccines Sales, 2017-2028
6.5.3 Germany Recombinant Vaccines Market Size, 2017-2028
6.5.4 France Recombinant Vaccines Market Size, 2017-2028
6.5.5 U.K. Recombinant Vaccines Market Size, 2017-2028
6.5.6 Italy Recombinant Vaccines Market Size, 2017-2028
6.5.7 Russia Recombinant Vaccines Market Size, 2017-2028
6.5.8 Nordic Countries Recombinant Vaccines Market Size, 2017-2028
6.5.9 Benelux Recombinant Vaccines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Recombinant Vaccines Revenue, 2017-2028
6.6.2 By Region - Asia Recombinant Vaccines Sales, 2017-2028
6.6.3 China Recombinant Vaccines Market Size, 2017-2028
6.6.4 Japan Recombinant Vaccines Market Size, 2017-2028
6.6.5 South Korea Recombinant Vaccines Market Size, 2017-2028
6.6.6 Southeast Asia Recombinant Vaccines Market Size, 2017-2028
6.6.7 India Recombinant Vaccines Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Recombinant Vaccines Revenue, 2017-2028
6.7.2 By Country - South America Recombinant Vaccines Sales, 2017-2028
6.7.3 Brazil Recombinant Vaccines Market Size, 2017-2028
6.7.4 Argentina Recombinant Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Vaccines Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Recombinant Vaccines Sales, 2017-2028
6.8.3 Turkey Recombinant Vaccines Market Size, 2017-2028
6.8.4 Israel Recombinant Vaccines Market Size, 2017-2028
6.8.5 Saudi Arabia Recombinant Vaccines Market Size, 2017-2028
6.8.6 UAE Recombinant Vaccines Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Merck & Co., Inc
7.1.1 Merck & Co., Inc Corporate Summary
7.1.2 Merck & Co., Inc Business Overview
7.1.3 Merck & Co., Inc Recombinant Vaccines Major Product Offerings
7.1.4 Merck & Co., Inc Recombinant Vaccines Sales and Revenue in Global (2017-2022)
7.1.5 Merck & Co., Inc Key News
7.2 Green Cross Corporation
7.2.1 Green Cross Corporation Corporate Summary
7.2.2 Green Cross Corporation Business Overview
7.2.3 Green Cross Corporation Recombinant Vaccines Major Product Offerings
7.2.4 Green Cross Corporation Recombinant Vaccines Sales and Revenue in Global (2017-2022)
7.2.5 Green Cross Corporation Key News
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Corporate Summary
7.3.2 Pfizer Inc. Business Overview
7.3.3 Pfizer Inc. Recombinant Vaccines Major Product Offerings
7.3.4 Pfizer Inc. Recombinant Vaccines Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Inc. Key News
7.4 Bayer AG
7.4.1 Bayer AG Corporate Summary
7.4.2 Bayer AG Business Overview
7.4.3 Bayer AG Recombinant Vaccines Major Product Offerings
7.4.4 Bayer AG Recombinant Vaccines Sales and Revenue in Global (2017-2022)
7.4.5 Bayer AG Key News
7.5 Sanofi S A.
7.5.1 Sanofi S A. Corporate Summary
7.5.2 Sanofi S A. Business Overview
7.5.3 Sanofi S A. Recombinant Vaccines Major Product Offerings
7.5.4 Sanofi S A. Recombinant Vaccines Sales and Revenue in Global (2017-2022)
7.5.5 Sanofi S A. Key News
7.6 Protein Science Corporation
7.6.1 Protein Science Corporation Corporate Summary
7.6.2 Protein Science Corporation Business Overview
7.6.3 Protein Science Corporation Recombinant Vaccines Major Product Offerings
7.6.4 Protein Science Corporation Recombinant Vaccines Sales and Revenue in Global (2017-2022)
7.6.5 Protein Science Corporation Key News
7.7 GlaxoSmithKline Plc.
7.7.1 GlaxoSmithKline Plc. Corporate Summary
7.7.2 GlaxoSmithKline Plc. Business Overview
7.7.3 GlaxoSmithKline Plc. Recombinant Vaccines Major Product Offerings
7.7.4 GlaxoSmithKline Plc. Recombinant Vaccines Sales and Revenue in Global (2017-2022)
7.7.5 GlaxoSmithKline Plc. Key News
7.8 Novartis AG
7.8.1 Novartis AG Corporate Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Recombinant Vaccines Major Product Offerings
7.8.4 Novartis AG Recombinant Vaccines Sales and Revenue in Global (2017-2022)
7.8.5 Novartis AG Key News
7.9 Bharat Biotech
7.9.1 Bharat Biotech Corporate Summary
7.9.2 Bharat Biotech Business Overview
7.9.3 Bharat Biotech Recombinant Vaccines Major Product Offerings
7.9.4 Bharat Biotech Recombinant Vaccines Sales and Revenue in Global (2017-2022)
7.9.5 Bharat Biotech Key News
8 Global Recombinant Vaccines Production Capacity, Analysis
8.1 Global Recombinant Vaccines Production Capacity, 2017-2028
8.2 Recombinant Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Vaccines Supply Chain Analysis
10.1 Recombinant Vaccines Industry Value Chain
10.2 Recombinant Vaccines Upstream Market
10.3 Recombinant Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Recombinant Vaccines in Global Market
Table 2. Top Recombinant Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Recombinant Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Recombinant Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Recombinant Vaccines Sales by Companies, (K Units), 2017-2022
Table 6. Global Recombinant Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Recombinant Vaccines Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Recombinant Vaccines Product Type
Table 9. List of Global Tier 1 Recombinant Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Recombinant Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Recombinant Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Recombinant Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Recombinant Vaccines Sales (K Units), 2017-2022
Table 15. By Type - Global Recombinant Vaccines Sales (K Units), 2023-2028
Table 16. By Application - Global Recombinant Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Recombinant Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Recombinant Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Recombinant Vaccines Sales (K Units), 2017-2022
Table 20. By Application - Global Recombinant Vaccines Sales (K Units), 2023-2028
Table 21. By Region - Global Recombinant Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Recombinant Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Recombinant Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Recombinant Vaccines Sales (K Units), 2017-2022
Table 25. By Region - Global Recombinant Vaccines Sales (K Units), 2023-2028
Table 26. By Country - North America Recombinant Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Recombinant Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Recombinant Vaccines Sales, (K Units), 2017-2022
Table 29. By Country - North America Recombinant Vaccines Sales, (K Units), 2023-2028
Table 30. By Country - Europe Recombinant Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Recombinant Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Recombinant Vaccines Sales, (K Units), 2017-2022
Table 33. By Country - Europe Recombinant Vaccines Sales, (K Units), 2023-2028
Table 34. By Region - Asia Recombinant Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Recombinant Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Recombinant Vaccines Sales, (K Units), 2017-2022
Table 37. By Region - Asia Recombinant Vaccines Sales, (K Units), 2023-2028
Table 38. By Country - South America Recombinant Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Recombinant Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Recombinant Vaccines Sales, (K Units), 2017-2022
Table 41. By Country - South America Recombinant Vaccines Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Recombinant Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Recombinant Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Recombinant Vaccines Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Recombinant Vaccines Sales, (K Units), 2023-2028
Table 46. Merck & Co., Inc Corporate Summary
Table 47. Merck & Co., Inc Recombinant Vaccines Product Offerings
Table 48. Merck & Co., Inc Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Green Cross Corporation Corporate Summary
Table 50. Green Cross Corporation Recombinant Vaccines Product Offerings
Table 51. Green Cross Corporation Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Pfizer Inc. Corporate Summary
Table 53. Pfizer Inc. Recombinant Vaccines Product Offerings
Table 54. Pfizer Inc. Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Bayer AG Corporate Summary
Table 56. Bayer AG Recombinant Vaccines Product Offerings
Table 57. Bayer AG Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Sanofi S A. Corporate Summary
Table 59. Sanofi S A. Recombinant Vaccines Product Offerings
Table 60. Sanofi S A. Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Protein Science Corporation Corporate Summary
Table 62. Protein Science Corporation Recombinant Vaccines Product Offerings
Table 63. Protein Science Corporation Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. GlaxoSmithKline Plc. Corporate Summary
Table 65. GlaxoSmithKline Plc. Recombinant Vaccines Product Offerings
Table 66. GlaxoSmithKline Plc. Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Novartis AG Corporate Summary
Table 68. Novartis AG Recombinant Vaccines Product Offerings
Table 69. Novartis AG Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Bharat Biotech Corporate Summary
Table 71. Bharat Biotech Recombinant Vaccines Product Offerings
Table 72. Bharat Biotech Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Recombinant Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 74. Global Recombinant Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Recombinant Vaccines Production by Region, 2017-2022 (K Units)
Table 76. Global Recombinant Vaccines Production by Region, 2023-2028 (K Units)
Table 77. Recombinant Vaccines Market Opportunities & Trends in Global Market
Table 78. Recombinant Vaccines Market Drivers in Global Market
Table 79. Recombinant Vaccines Market Restraints in Global Market
Table 80. Recombinant Vaccines Raw Materials
Table 81. Recombinant Vaccines Raw Materials Suppliers in Global Market
Table 82. Typical Recombinant Vaccines Downstream
Table 83. Recombinant Vaccines Downstream Clients in Global Market
Table 84. Recombinant Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Recombinant Vaccines Segment by Type
Figure 2. Recombinant Vaccines Segment by Application
Figure 3. Global Recombinant Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Recombinant Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Recombinant Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Recombinant Vaccines Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Vaccines Revenue in 2021
Figure 9. By Type - Global Recombinant Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Recombinant Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Recombinant Vaccines Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Recombinant Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Recombinant Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Recombinant Vaccines Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Recombinant Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Recombinant Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Recombinant Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Recombinant Vaccines Sales Market Share, 2017-2028
Figure 19. US Recombinant Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Recombinant Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Recombinant Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Recombinant Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Recombinant Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Recombinant Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Recombinant Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Recombinant Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Recombinant Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Recombinant Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Recombinant Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Recombinant Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Recombinant Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Recombinant Vaccines Sales Market Share, 2017-2028
Figure 33. China Recombinant Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Recombinant Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Recombinant Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Recombinant Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Recombinant Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Recombinant Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Recombinant Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Recombinant Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Recombinant Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Recombinant Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Recombinant Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Recombinant Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Recombinant Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Recombinant Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Recombinant Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Recombinant Vaccines Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Recombinant Vaccines by Region, 2021 VS 2028
Figure 50. Recombinant Vaccines Industry Value Chain
Figure 51. Marketing Channels
Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 87
The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
Global Esomeprazole Magnesium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 74
The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030.
North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
Global Combination Therapy Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
Global Axitinib Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 68
The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
Global Lyme Disease Vaccine Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 70
The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi.
The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at......
Global Transdermal Absorption Patch Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
Global Ketoprofen Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis
The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
Global Methyl Salicylate Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 82
The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
Global Diclofenac Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
